Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Klebsiella pneumoniae Fimbrial Subunit Type 3 (mrkA), N-His-SUMO

Name: Recombinant Klebsiella pneumoniae Fimbrial Subunit Type 3 (mrkA), N-His-SUMO
SKU: VG9F320
Rating: 5 (1 reviews)

Cat. No.VG9F320

Product TypeVeterinary Antigens

Size

Inquiry Now Add to Inquiry List

Product Overview

BioVenic's Recombinant Klebsiella pneumoniae Fimbrial Subunit Type 3 (mrkA), N-His-SUMO is a recombinant protein expressed from E.coli. Its predicted molecular weight is 34.5 kDa. The purity is>90% (SDS-PAGE).

Specifications

Type Recombinant Protein

Species Bacterium

Expression System E.coli

Purity >90% (SDS-PAGE)

Predicted Molecular Weight 34.5 kDa

Physical State Lyophilized

Formulation Tris/PBS-based buffer, 6% Trehalose.

Target Information

Klebsiella species are well-recognized as rod-shaped, gram-negative, non-motile, lactose-fermenting, and facultatively anaerobic bacteria within the Enterobacteriaceae family. Klebsiella pneumoniae is an opportunistic pathogen linked to various complex clinical infections in both humans and animals. Fimbrial subunit type 3 is located in the fimbrium of Klebsiella pneumoniae.

Protein Klebsiella pneumoniae Fimbrial Subunit Type 3 (mrkA)

Protein Synonym Fimbrial subunit type 3; mrkA

Gene ID 69758164

UniProt ID P12267

Shipping and Storage

This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL. Aliquote the reconstituted solution to minimise freeze-thaw cycles.